Estimating the health state utility of patients with HER2-gBCRA+ metastatic breast cancer treated with olaparib or chemotherapy via a mapping analysis of EORTC QLQ-C30 data collected in the OlympiAD clinical trial Meeting Abstract
| Authors: | Robson, M.; Hettle, R.; Degboe, A.; Saunders, O.; Cain, T.; Kilvert, H.; Johnson, H. |
| Abstract Title: | Estimating the health state utility of patients with HER2-gBCRA+ metastatic breast cancer treated with olaparib or chemotherapy via a mapping analysis of EORTC QLQ-C30 data collected in the OlympiAD clinical trial |
| Meeting Title: | 23nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) |
| Journal Title: | Value in Health |
| Volume: | 21 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 May 19-23 |
| Meeting Location: | Baltimore, MD |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2018-05-01 |
| Start Page: | S12 |
| Language: | English |
| ACCESSION: | WOS:000437739100058 |
| DOI: | 10.1016/j.jval.2018.04.058 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PP3 -- Source: Wos |
